OIG Targets FL Providers for Medicare Abuses
Miami-Dade County in Florida was again targeted for higher per capita medical spending and questionable billing practices during 2009 in two Office of Inspector General reports, one which scrutinized spending on inhaler medications and the other which examined costs for outpatient therapy.
In the first report, the agency found that Medicare paid suppliers in South Florida for up to 10 times more units of the inhalation drug arformoterol than the drug's manufacturer and the three largest wholesalers distributed for sale in the area in 2008 and the first half of 2009, suggesting that suppliers were billing for drugs that were never purchased.
"Based on data for the manufacturer and the 3 largest wholesalers, Florida suppliers billed Medicare for up to 17 times than the amount that could have legitimately been billed," the OIG report said.
"Furthermore, the $62 million billed by South Florida suppliers for arformoterol during this period far exceeds the total possible sales in the area," the agency said. "Based on sales data for arformoterol's manufacturer and the three largest wholesalers, it does not appear that these suppliers purchased enough of the drug to justify these payments."
- Resisting the Healthcare Consolidation Frenzy
- Give Nurses in Wheelchairs a Chance
- MGMA Urges 'End-to-End' ICD-10 Testing
- New G-Codes to Pay Doctors for Broad Array of Non-Face-to-Face Care
- HL20: George Halvorson—Expectations for Success
- 3 Better Ways to Market Bariatric Surgery
- Scary Financial Challenges for 2014
- Top 3 Health Plan Game Changers of 2013
- MU Compliance Announcement Sparks Concern, Confusion
- 1 in 5 CT Screenings for Lung Cancer Results in Overdiagnosis